Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Astria Therapeutics, Inc. (ATXS)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -44.2% | -108.6% | -167.4% | -113.3% | -273.6% | -470.4% | -562.9% | |
| ROIC (including intangibles) | -26.5% | -77.8% | -215.4% | -99.1% | -128.8% | 2275.8% | -279.7% | 40588.5% |
| ROE | -24.2% | -25.5% | -92.0% | -75.8% | -75.5% | -229.8% | -122.3% | -62.7% |
| ROA | -23.2% | -24.5% | -78.9% | -64.8% | -67.3% | -151.4% | -88.4% | -49.3% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | | | | | | 0.0 | 0.0 | 0.0 |
| Days payables outstanding | | | | | | | 1,363.9 | 4,847.2 |
| Cash conversion cycle | | | | | | | -1,363.9 | -4,847.2 |
|